Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Clarus Lifesciences II, L.P. Create: Alert

All | News | Filings
Date FiledTypeDescription
06/12/2019 SC 13D/A Clarus Lifesciences II, L.P. reports a 0.3% stake in NanoString Technologies, Inc.
03/22/2019 SC 13D/A Clarus Lifesciences II, L.P. reports a 6.1% stake in NanoString Technologies, Inc.
03/22/2019 4 Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on NanoString Technologies Inc
Txns: Sold 2,000,000 shares @ $21.62, valued at $43.2M
02/14/2019 SC 13G/A Clarus Lifesciences II, L.P. reports a 4.2% stake in Restoration Robotics, Inc.
09/19/2018 4 Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on NanoString Technologies Inc
Txns: Sold 85,823 shares @ $15.99, valued at $1.4M
Exercised (in-or-at-the-money) 162,408 warrants @ $8.448, valued at $1.4M
07/25/2018 SC 13D/A Clarus Lifesciences II, L.P. reports a 14% stake in NanoString Technologies, Inc.
04/04/2018 SC 13D/A Clarus Lifesciences II, L.P. reports a 7% stake in Catabasis Pharmaceuticals, Inc.
02/12/2018 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/09/2018 SC 13D/A Clarus Lifesciences II, L.P. reports a 12% stake in Catabasis Pharmaceuticals, Inc.
01/03/2018 4 Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on NanoString Technologies Inc
Txns: Granted 10,168 options to buy @ $7.47, valued at $76k
10/17/2017 4 Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on Restoration Robotics Inc
Txns: Converted 3,389,105 shares @ $0
Converted 180,881 shares @ $7, valued at $1.3M
Converted 3,389,105 preferred shares @ $0
Converted convertible notes @ $7, valued at $0
10/13/2017 4 Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on Restoration Robotics Inc
Txns: Acquired convertible notes @ $7, valued at $0
10/11/2017 3 Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 3 on Restoration Robotics Inc
06/07/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/13/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
01/04/2017 4 Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on NanoString Technologies Inc
Txns: Granted 8,611 options to buy @ $22.3, valued at $192k
10/04/2016 SC 13D/A CATABASIS PHARMACEUTICALS INC reports a 15.4% stake in Catabasis Pharmaceuticals, Inc.
03/16/2016 SC 13D/A Clarus Lifesciences II, L.P. reports a 0% stake in TetraLogic Pharmaceuticals Corporation
02/10/2016 4 Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP
02/05/2016 4 Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP
02/05/2016 SC 13D/A Clarus Lifesciences II, L.P. reports a 16% stake in TetraLogic Pharmaceuticals Corporation
11/04/2013 SC 13D Clarus Lifesciences II, L.P. reports a 16.5% stake in Aerie Pharmaceuticals, Inc.
10/28/2013 4 Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC
10/25/2013 3 Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 3 on AERIE PHARMACEUTICALS INC
10/02/2013 4 Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on Ophthotech Corp.
06/25/2013 3 Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 3 on NanoString Technologies Inc
06/06/2012 4 Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Disposed of 10,942,468 shares @ $0
06/04/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
08/25/2010 SC 13D/A Form SC 13D - General statement of acquisition of beneficial ownership [amend]
08/20/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
01/13/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
01/08/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
01/08/2010 SC 13D/A Clarus Lifesciences II, L.P. reports a 20.1% stake in Achillion Pharmaceuticals, Inc.
12/29/2009 4 Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Sold 3,600 shares @ $3.5264, valued at $12.7k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy